The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program

The vaccination program is reducing the burden of COVID-19. However, recently, COVID-19 infections have been increasing across Europe, providing evidence that vaccine efficacy is waning. Consequently, booster doses are required to restore immunity levels. However, the relative risk–benefit ratio of...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiri, Tinevimbo, Evans, Marc, Talarico, Carla A., Morgan, Angharad R., Mussad, Maaz, Buck, Philip O., McEwan, Phil, Strain, William David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880242/
https://www.ncbi.nlm.nih.gov/pubmed/35214599
http://dx.doi.org/10.3390/vaccines10020140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880242/
https://www.ncbi.nlm.nih.gov/pubmed/35214599
http://dx.doi.org/10.3390/vaccines10020140

Ejemplares similares